Methotrexate 25mg/mL; soln for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...
For patients with brain metastases the methotrexate dose is increased to 1 g/m 2 with folinic acid rescue 30 mg given 8 h intravenously for 3 days, commencing 32 h after the start of the methotrexate ...
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. The in vivo response to prephase corticosteroid therapy for 1 week has been ...
Paraplegia and Paraparesis From Intrathecal Methotrexate and Cytarabine Contaminated With Trace Amounts of Vincristine in China During 2007 From June 2000 through October 2007, 356 children with ALL ...
LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...
Methotrexate injectable intravenous (IV) solution is only available as a generic drug. It doesn’t have a brand-name version. Methotrexate comes in four forms: injectable IV solution, self-injectable ...
Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. By March, the American Society of Health-System Pharmacists ...
Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...
Methotrexate is a prescription medication. It comes in four forms: self-injectable solution, injectable IV solution, oral tablet, and oral solution. For the self-injectable solution, you can receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback